A WHO report (2017) claims 10.5 percent of medicines sold in low and middle-income countries, including India, are substandard and falsified which is a serious threat to patient safety with dangerous side effects and may lead to other health problems.
Original source: https://health.economictimes.indiatimes.com/news/pharma/81342614?utm_source=RSS&utm_medium=ETRSS
